Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Change in Account Payables (2020 - 2022)

Historic Change in Account Payables for CureVac (CVAC) over the last 3 years, with Q1 2022 value amounting to -$108.7 million.

  • CureVac's Change in Account Payables fell 39587.16% to -$108.7 million in Q1 2022 from the same period last year, while for Mar 2022 it was $585.2 million, marking a year-over-year change of. This contributed to the annual value of -$150.2 million for FY2024, which is 36388.04% down from last year.
  • CureVac's Change in Account Payables amounted to -$108.7 million in Q1 2022, which was down 39587.16% from $56.4 million recorded in Q4 2021.
  • CureVac's 5-year Change in Account Payables high stood at $600.7 million for Q4 2020, and its period low was -$108.7 million during Q1 2022.
  • Its 3-year average for Change in Account Payables is $146.3 million, with a median of $46.6 million in 2021.
  • Its Change in Account Payables has fluctuated over the past 5 years, first crashed by 9061.3% in 2021, then plummeted by 39587.16% in 2022.
  • Quarter analysis of 3 years shows CureVac's Change in Account Payables stood at $600.7 million in 2020, then crashed by 90.61% to $56.4 million in 2021, then tumbled by 292.73% to -$108.7 million in 2022.
  • Its Change in Account Payables stands at -$108.7 million for Q1 2022, versus $56.4 million for Q4 2021 and $36.7 million for Q1 2021.